{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T04:47:47Z","timestamp":1792126067819,"version":"4.4.0"},"reference-count":128,"publisher":"Informa UK Limited","issue":"1","license":[{"start":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T00:00:00Z","timestamp":1792022400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T00:00:00Z","timestamp":1792022400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/doi.org\/10.1080\/policies-text-data-mining"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["NRF-2022R1A2C1003930"],"award-info":[{"award-number":["NRF-2022R1A2C1003930"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"name":"the Medical Research Centre (MRC) Program","award":["NRF-2022R1A5A2027161"],"award-info":[{"award-number":["NRF-2022R1A5A2027161"]}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Drug Delivery"],"published-print":{"date-parts":[[2026,12,31]]},"DOI":"10.1080\/10717544.2026.2741456","type":"journal-article","created":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T04:25:21Z","timestamp":1792124721000},"update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":0,"title":["Overcoming the nuclear barrier in nonviral gene therapy: mechanisms, carrier design, and translational perspectives on NLS peptide and DNA targeting sequence strategies"],"prefix":"10.1080","volume":"33","author":[{"given":"Taegeun","family":"Lee","sequence":"first","affiliation":[{"name":"Department of Anatomy, School of Medicine, Pusan National University","place":["Yangsan, Republic of Korea"]},{"name":"Research Center for Molecular Control for Cancer Cell Diversity, Pusan National University","place":["Yangsan, Republic of Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ye-Rin","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Anatomy, School of Medicine, Pusan National University","place":["Yangsan, Republic of Korea"]},{"name":"Research Center for Molecular Control for Cancer Cell Diversity, Pusan National University","place":["Yangsan, Republic of Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Euijin","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Anatomy, School of Medicine, Pusan National University","place":["Yangsan, Republic of Korea"]},{"name":"Research Center for Molecular Control for Cancer Cell Diversity, Pusan National University","place":["Yangsan, Republic of Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sae-Ock","family":"Oh","sequence":"additional","affiliation":[{"name":"Department of Anatomy, School of Medicine, Pusan National University","place":["Yangsan, Republic of Korea"]},{"name":"Research Center for Molecular Control for Cancer Cell Diversity, Pusan National University","place":["Yangsan, Republic of Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2026,10,15]]},"reference":[{"key":"e_1_3_7_2_1","doi-asserted-by":"publisher","DOI":"10.1006\/jmcc.1999.1085"},{"key":"e_1_3_7_3_1","doi-asserted-by":"publisher","DOI":"10.31083\/FBL47606"},{"key":"e_1_3_7_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2019.12.008"},{"key":"e_1_3_7_5_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-19-2217"},{"key":"e_1_3_7_6_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.272.47.29475"},{"key":"e_1_3_7_7_1","doi-asserted-by":"publisher","DOI":"10.1002\/1097-4644(20010501)81:2<333::AID-JCB1048>3.0.CO;2-D"},{"key":"e_1_3_7_8_1","doi-asserted-by":"publisher","DOI":"10.1038\/gt.2011.96"},{"key":"e_1_3_7_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2009.04.016"},{"key":"e_1_3_7_10_1","doi-asserted-by":"publisher","DOI":"10.1042\/BSR20160616"},{"key":"e_1_3_7_11_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrm.2016.147"},{"key":"e_1_3_7_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(11)60394-2"},{"key":"e_1_3_7_13_1","doi-asserted-by":"publisher","DOI":"10.1042\/BSR20201026"},{"key":"e_1_3_7_14_1","doi-asserted-by":"publisher","DOI":"10.1093\/emboj\/cdg516"},{"key":"e_1_3_7_15_1","doi-asserted-by":"publisher","DOI":"10.1038\/11726"},{"key":"e_1_3_7_16_1","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkn287"},{"key":"e_1_3_7_17_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.gt.3301102"},{"key":"e_1_3_7_18_1","doi-asserted-by":"publisher","DOI":"10.1186\/1472-6750-3-14"},{"key":"e_1_3_7_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2024.122799"},{"key":"e_1_3_7_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbamcr.2010.10.014"},{"key":"e_1_3_7_21_1","doi-asserted-by":"publisher","DOI":"10.1021\/bc980061a"},{"key":"e_1_3_7_22_1","volume-title":"Tavokinogene telseplasmid with electroporation and pembrolizumab in patients with stage III\/IV melanoma (KEYNOTE-695)","author":"ClinicalTrials.gov","year":"2026","unstructured":"ClinicalTrials.gov . 2026a. Tavokinogene telseplasmid with electroporation and pembrolizumab in patients with stage III\/IV melanoma (KEYNOTE-695). National Library of Medicine: Bethesda (MD). https:\/\/clinicaltrials.gov\/study\/NCT03132675."},{"key":"e_1_3_7_23_1","volume-title":"Study of combined SGT-53 plus gemcitabine\/nab-paclitaxel for metastatic pancreatic cancer","author":"ClinicalTrials.gov","year":"2026","unstructured":"ClinicalTrials.gov . 2026b. Study of combined SGT-53 plus gemcitabine\/nab-paclitaxel for metastatic pancreatic cancer. National Library of Medicine: Bethesda (MD). https:\/\/clinicaltrials.gov\/study\/NCT02340117"},{"key":"e_1_3_7_24_1","volume-title":"Safety and efficacystudy of Allovectin-7 in patients with metastatic melanoma. Identifier NCT00395070","author":"ClinicalTrials.gov","year":"2026","unstructured":"ClinicalTrials.gov . 2026c. Safety and efficacystudy of Allovectin-7 in patients with metastatic melanoma. Identifier NCT00395070. National Library of Medicine: Bethesda (MD). https:\/\/clinicaltrials.gov\/study\/NCT00395070#lt;\/comment#gt;."},{"key":"e_1_3_7_25_1","volume-title":"CODEX: study of inodiftagene vixteplasmid (BC-819) in BCG-unresponsive non-muscle-invasive bladder cancer","author":"ClinicalTrials.gov","year":"2026","unstructured":"ClinicalTrials.gov . 2026d. CODEX: study of inodiftagene vixteplasmid (BC-819) in BCG-unresponsive non-muscle-invasive bladder cancer. Identifier NCT03719300NCT03719300. National Library of Medicine: Bethesda (MD). https:\/\/clinicaltrials.gov\/study\/NCT03719300"},{"key":"e_1_3_7_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2008.12.016"},{"issue":"1","key":"e_1_3_7_27_1","first-page":"48","article-title":"Rapid targeting of plasmid DNA to zebrafish embryo nuclei by the nuclear localization signal of SV40 T antigen","volume":"6","author":"Collas P","year":"1997","unstructured":"Collas P , Alestr\u00f6m P . 1997. Rapid targeting of plasmid DNA to zebrafish embryo nuclei by the nuclear localization signal of SV40 T antigen. Mol Mar Biol Biotechnol. 6(1):48\u201358.","journal-title":"Mol Mar Biol Biotechnol"},{"key":"e_1_3_7_28_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF01980210"},{"key":"e_1_3_7_29_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2007.15.6794"},{"key":"e_1_3_7_30_1","doi-asserted-by":"publisher","DOI":"10.1006\/excr.1996.3427"},{"key":"e_1_3_7_31_1","doi-asserted-by":"publisher","DOI":"10.1006\/excr.1999.4716"},{"key":"e_1_3_7_32_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.gt.3302534"},{"key":"e_1_3_7_33_1","doi-asserted-by":"publisher","DOI":"10.1038\/gt.2009.166"},{"key":"e_1_3_7_34_1","doi-asserted-by":"publisher","DOI":"10.4014\/jmb.1411.11074"},{"key":"e_1_3_7_35_1","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/23.2.217"},{"key":"e_1_3_7_36_1","doi-asserted-by":"publisher","DOI":"10.1002\/jgm.174"},{"key":"e_1_3_7_37_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M002217200"},{"key":"e_1_3_7_38_1","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adq8773"},{"key":"e_1_3_7_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2013.12.011"},{"key":"e_1_3_7_40_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.cmr.0000232299.44902.41"},{"key":"e_1_3_7_41_1","doi-asserted-by":"publisher","DOI":"10.1039\/D1CS00269D"},{"key":"e_1_3_7_42_1","doi-asserted-by":"publisher","DOI":"10.1038\/gt.2016.52"},{"key":"e_1_3_7_43_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.mtbio.2025.102588"},{"key":"e_1_3_7_44_1","doi-asserted-by":"publisher","DOI":"10.1002\/jgm.915"},{"key":"e_1_3_7_45_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.nantod.2016.02.004"},{"key":"e_1_3_7_46_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0248-4900(03)00007-8"},{"key":"e_1_3_7_47_1","doi-asserted-by":"publisher","DOI":"10.1210\/endo.138.4.5177"},{"key":"e_1_3_7_48_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrg2971"},{"key":"e_1_3_7_49_1","doi-asserted-by":"publisher","DOI":"10.1111\/cts.12977"},{"key":"e_1_3_7_50_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(22)00151-9"},{"key":"e_1_3_7_51_1","doi-asserted-by":"publisher","DOI":"10.1002\/j.1460-2075.1994.tb06730.x"},{"key":"e_1_3_7_52_1","doi-asserted-by":"publisher","DOI":"10.1038\/gt.2010.31"},{"key":"e_1_3_7_53_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.R600026200"},{"key":"e_1_3_7_54_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.omtn.2021.03.012"},{"key":"e_1_3_7_55_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.gt.3300867"},{"key":"e_1_3_7_56_1","doi-asserted-by":"publisher","DOI":"10.1159\/000053993"},{"key":"e_1_3_7_57_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2013.11.027"},{"key":"e_1_3_7_58_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-018-0358-x"},{"key":"e_1_3_7_59_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-065X.2010.00980.x"},{"key":"e_1_3_7_60_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbamcr.2010.10.012"},{"key":"e_1_3_7_61_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.70400"},{"key":"e_1_3_7_62_1","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics14091861"},{"key":"e_1_3_7_63_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2014.06.048"},{"key":"e_1_3_7_64_1","doi-asserted-by":"publisher","DOI":"10.1006\/mthe.2001.0312"},{"key":"e_1_3_7_65_1","doi-asserted-by":"publisher","DOI":"10.1089\/hum.2005.16.200"},{"key":"e_1_3_7_66_1","doi-asserted-by":"publisher","DOI":"10.1042\/BSR20170995"},{"key":"e_1_3_7_67_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0000589"},{"key":"e_1_3_7_68_1","doi-asserted-by":"publisher","DOI":"10.1038\/gt.2008.83"},{"key":"e_1_3_7_69_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2009.02.008"},{"key":"e_1_3_7_70_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bpj.2024.11.3313"},{"key":"e_1_3_7_71_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-68167-5"},{"key":"e_1_3_7_72_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.abm9506"},{"key":"e_1_3_7_73_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2796.2003.01296.x"},{"issue":"6","key":"e_1_3_7_74_1","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/S0169-409X(03)00050-4","article-title":"Emerging significance of plasmid DNA nuclear import in gene therapy","volume":"55","author":"Munkonge FM","year":"2003","unstructured":"Munkonge FM , Dean DA , Hillery E et al. 2003. Emerging significance of plasmid DNA nuclear import in gene therapy. Adv Drug Deliv Rev. 55(6):749\u2013760.","journal-title":"Adv Drug Deliv Rev"},{"key":"e_1_3_7_75_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.gt.3301401"},{"key":"e_1_3_7_76_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2004.11.024"},{"key":"e_1_3_7_77_1","doi-asserted-by":"publisher","DOI":"10.1006\/excr.1996.0369"},{"key":"e_1_3_7_78_1","doi-asserted-by":"publisher","DOI":"10.1039\/D2CS00049K"},{"key":"e_1_3_7_79_1","doi-asserted-by":"publisher","DOI":"10.1023\/A:1007693805849"},{"key":"e_1_3_7_80_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10439-009-9768-0"},{"key":"e_1_3_7_81_1","doi-asserted-by":"publisher","DOI":"10.2174\/1875397301004010043"},{"key":"e_1_3_7_82_1","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.19.2.1218"},{"key":"e_1_3_7_83_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0092-8674(00)80173-7"},{"key":"e_1_3_7_84_1","doi-asserted-by":"publisher","DOI":"10.1534\/genetics.108.097303"},{"key":"e_1_3_7_85_1","doi-asserted-by":"publisher","DOI":"10.1042\/BJ20141186"},{"key":"e_1_3_7_86_1","doi-asserted-by":"publisher","DOI":"10.1021\/mp200372s"},{"key":"e_1_3_7_87_1","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(91)90245-T"},{"key":"e_1_3_7_88_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.molpharmaceut.5b00645"},{"key":"e_1_3_7_89_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biotechadv.2009.03.004"},{"key":"e_1_3_7_90_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.coi.2011.03.008"},{"key":"e_1_3_7_91_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M002208200"},{"key":"e_1_3_7_92_1","doi-asserted-by":"publisher","DOI":"10.1038\/nbt0198-80"},{"key":"e_1_3_7_93_1","doi-asserted-by":"publisher","DOI":"10.1038\/mt.2013.32"},{"key":"e_1_3_7_94_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2009.03.040"},{"key":"e_1_3_7_95_1","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01542-14"},{"key":"e_1_3_7_96_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2008.08.006"},{"key":"e_1_3_7_97_1","doi-asserted-by":"publisher","DOI":"10.1002\/bit.29019"},{"key":"e_1_3_7_98_1","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.138.6.1181"},{"key":"e_1_3_7_99_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2024.115354"},{"key":"e_1_3_7_100_1","doi-asserted-by":"publisher","DOI":"10.1021\/cb2000296"},{"key":"e_1_3_7_101_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M116.730218"},{"key":"e_1_3_7_102_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrm2114"},{"key":"e_1_3_7_103_1","doi-asserted-by":"publisher","DOI":"10.1038\/12860"},{"key":"e_1_3_7_104_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2024.124492"},{"key":"e_1_3_7_105_1","doi-asserted-by":"publisher","DOI":"10.1039\/C9SM01990A"},{"key":"e_1_3_7_106_1","doi-asserted-by":"publisher","DOI":"10.1039\/D2BM00826B"},{"key":"e_1_3_7_107_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11095-006-9132-0"},{"key":"e_1_3_7_108_1","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.19.2.1210"},{"key":"e_1_3_7_109_1","unstructured":"U.S. Food and Drug Administration . 2026. Approved cellular and gene therapy products. FDA: Silver Spring (MD). [Available from: accessed Aug 10]. https:\/\/www.FDA.gov\/vaccines-blood-biologics\/cellular-gene-therapy-products\/approved-cellular-and-gene-therapy-products"},{"key":"e_1_3_7_110_1","unstructured":"U.S. Food and Drug Administration . 2007. Considerations for plasmid DNA vaccines for infectious disease indications: guidance for industry. Center for Biologics Evaluation and Research FDA: Rockville (MD). [Available from:[accessed 2026 Aug 10]. https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/considerations-plasmid-dna-vaccines-infectious-disease-indications"},{"key":"e_1_3_7_111_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.gt.3300924"},{"key":"e_1_3_7_112_1","doi-asserted-by":"publisher","DOI":"10.1002\/jgm.643"},{"key":"e_1_3_7_113_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11095-011-0407-8"},{"key":"e_1_3_7_114_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2426960122"},{"key":"e_1_3_7_115_1","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/23.15.3003"},{"key":"e_1_3_7_116_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.272.25.16010"},{"key":"e_1_3_7_117_1","first-page":"2513","article-title":"Transferrin-PEG-PE modified dexamethasone conjugated cationic lipid carrier mediated gene delivery system for tumor-targeted transfection","volume":"7","author":"Wang W","year":"2012","unstructured":"Wang W , Zhou F , Ge L et al. 2012. Transferrin-PEG-PE modified dexamethasone conjugated cationic lipid carrier mediated gene delivery system for tumor-targeted transfection. Int J Nanomedicine. 7:2513\u20132522.","journal-title":"Int J Nanomedicine"},{"key":"e_1_3_7_118_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.virol.2013.04.025"},{"key":"e_1_3_7_119_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0014-5793(00)02399-1"},{"key":"e_1_3_7_120_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.274.31.22025"},{"key":"e_1_3_7_121_1","doi-asserted-by":"publisher","DOI":"10.3109\/1061186X.2013.830310"},{"key":"e_1_3_7_122_1","doi-asserted-by":"publisher","DOI":"10.1021\/bc2005472"},{"key":"e_1_3_7_123_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.177.11.7889"},{"key":"e_1_3_7_124_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.gt.3302021"},{"key":"e_1_3_7_125_1","doi-asserted-by":"publisher","DOI":"10.3181\/0712-RM-331"},{"key":"e_1_3_7_126_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.96.1.91"},{"key":"e_1_3_7_127_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1916395117"},{"key":"e_1_3_7_128_1","doi-asserted-by":"publisher","DOI":"10.1021\/bc8003414"},{"key":"e_1_3_7_129_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.abd9776"}],"container-title":["Drug Delivery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/10717544.2026.2741456","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/full-xml\/10.1080\/10717544.2026.2741456","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/10717544.2026.2741456","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T04:25:25Z","timestamp":1792124725000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/10717544.2026.2741456"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,15]]},"references-count":128,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12,31]]}},"alternative-id":["10.1080\/10717544.2026.2741456"],"URL":"https:\/\/doi.org\/10.1080\/10717544.2026.2741456","relation":{},"ISSN":["1071-7544","1521-0464"],"issn-type":[{"value":"1071-7544","type":"print"},{"value":"1521-0464","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,15]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=idrd20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=idrd20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2026-06-02","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-09-11","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-09-25","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-10-15","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"2741456"}}